Cardiawave SA: Cardiawave Announces the Success of Its Clinical Trial to Treat Aortic Stenosis Using VALVOSOFT, Its Disruptive, Non-Invasive, Ultrasound Treatment

The trial with VALVOSOFT its disruptive, non-invasive, ultrasound treatment was proven to: be safe and feasible provide a sustained repair of the aortic valve improve quality of life

Related Keywords

Serbia ,Germany ,United States ,Paris ,France General ,France ,Netherlands ,Mris ,00 ,French ,Benjamin Bertrand ,Institut Langevin ,Kostenloser Wertpapierhandel ,James Palmer ,Professeur Emmanuel Messas ,Sophie Baratte ,Annie Florence Loyer ,Conseil Press Relations ,First In Human ,Georges Pompidou European Hospital ,Laboratoire Physique ,Transcatheter Aortic Valve Replacement ,Aortic Stenosis ,Press Relations ,Cardiawave ,Nnounces ,Success ,Linical ,Trial ,Treat ,Aortic ,Estenosis ,Sing ,Alvosoft ,Disruptive ,Nvasive ,Ultrasound ,Treatment ,